Analytical Data
-
基因名
hbhA
- Application
-
别名
hbhA;Heparin-binding hemagglutinin
-
种属
Mycobacterium tuberculosis
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P9WIP8
-
表达区间
2-199aa
-
氨基酸序列
AENSNIDDIKAPLLAALGAADLALATVNELITNLRERAEETRTDTRSRVEESRARLTKLQEDLPEQLTELREKFTAEELRKAAEGYLEAATSRYNELVERGEAALERLRSQQSFEEVSARAEGYVDQAVELTQEALGTVASQTRAVGERAAKLVGIELPKKAAPAKKAAPAKKAAPAKKAAAKKAPAKKAAAKKVTQK
-
分子量
28.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of recombinant proteins, particularly hbhA, has gained significant attention due to its potential applications in various fields, including vaccine development, therapeutic proteins, and enzyme engineering. hbhA, encoded by the hbhA gene, is a component found in certain bacterial strains and is implicated in various biological processes, including pathogenicity and host interactions. Research has shown that hbhA plays a crucial role in the immune response, making it a valuable candidate for vaccine development against specific infectious diseases. By utilizing recombinant DNA technology, scientists can produce large quantities of hbhA protein in heterologous systems, allowing for detailed functional studies and potential therapeutic applications. Furthermore, understanding the structure-function relationship of hbhA can facilitate the design of more effective vaccines or therapeutics. The ability to manipulate and express hbhA in a controlled environment opens avenues for investigating its mechanisms of action and exploring its immunogenic properties. Recent advancements in proteomics and bioinformatics have also enhanced the understanding of hbhA's role and its interactions at the molecular level, promoting further research into its utility in medical science. Overall, the exploration of hbhA as a recombinant protein embodies a critical intersection of microbiology, immunology, and biotechnology, highlighting its promise in addressing pressing health challenges.












